CDNA — CAREDX INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About CAREDX INC (CDNA)
CAREDX INC (CDNA) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Cathie Wood (ARK Investment Management), valued at $40M. Across recent filings, tracked investors recorded 3 new positions, 1 increased, 2 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in CDNA
How many top investors track CDNA
A small number of top investors own this.
CDNA Ownership Composition
How CAREDX INC is held across tracked investor types, based on reported 13F positions.
- Growth Funds92.0%
- Other8.0%
Tracked investors reporting CDNA
- Cathie WoodMar 31, 2026ARK Investment ManagementShares2.2MValue$38.7M% Portfolio0.30%
- Ken GriffinMar 31, 2026Citadel AdvisorsShares84.2KValue$1.5M% Portfolio0.00%
- Izzy EnglanderDec 31, 2025Millennium ManagementShares99.7KValue$1.9M% Portfolio0.00%
Recent activity
- $1.9MFeb 17, 2026
- Increased$38.7M(4.27%)May 12, 2026
- Reduced$12.6M(-0.83%)Feb 17, 2026
- Reduced$40.2M(-1.58%)Feb 11, 2026
- New$9.8MNov 14, 2025
- New$31.6MNov 12, 2025
Frequently asked questions
- How many institutional investors hold CDNA?
- 3 tracked institutional investors disclosed a position in CDNA (CAREDX INC) in their most recent 13F filing.
- Who is the largest institutional holder of CDNA?
- Cathie Wood, ARK Investment Management, holds the largest disclosed position in CDNA, valued at $40M.
- Did institutional ownership of CDNA increase or decrease?
- Across recent 13F filings, tracked investors recorded 3 new positions, 1 increased, 2 reduced, and 0 fully exited CDNA.
- Where does this CDNA ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.